Market Tracker

03/24 5:16pm ET

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

0.7057
Delayed Data
As of Mar 24
 +0.0293 / +4.33%
Today’s Change
0.28
Today|||52-Week Range
0.77
+128.83%
Year-to-Date
No recent news for Peregrine Pharmaceuticals Inc.

Today’s Trading

Previous close0.68
Today’s open0.68
Day’s range0.66 - 0.72
Volume3,038,526
Average volume (3 months)3,193,232
Market cap$210.1M
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+6.67%
Earnings growth (this year)+58.93%
Earnings growth (next 5 years)--
Revenue growth (last year)+66.86%
P/E ratioNM
Price/Sales1.71
Price/Book3.34

Competitors

 Today’s
change
Today’s
% change
SRNESorrento Therapeutic...-0.10-2.38%
STMLStemline Therapeutic...-0.05-0.59%
CEMPCempra Inc+0.05+1.23%
TRVNTrevena Inc-0.04-1.11%
Data as of 3:59pm ET, 03/24/2017

Financials

Next reporting dateJuly 17, 2017
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$44.7M
Annual profit (last year)-$55.7M
Net profit margin-124.54%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
CFO &
Principal Accounting Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts